Charles River Labs Intl buy UBS Group AG
Start price
09.11.23
/
50%
€158.95
Target price
09.11.24
€201.48
Performance (%)
11.89%
Price
09:30
€177.85
Summary
This prediction is currently active. The prediction currently has a performance of 11.89%. This prediction currently runs until 09.11.24. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Charles River Labs Intl | -2.589% | -2.589% |
iShares Core DAX® | 1.663% | 6.945% |
iShares Nasdaq 100 | 1.261% | 4.883% |
iShares Nikkei 225® | 0.654% | 10.007% |
iShares S&P 500 | 1.403% | 4.350% |
Comments by UBS_Group_AG for this prediction
In the thread Charles River Labs Intl diskutieren
Charles River Laboratories International, Inc. (NYSE: CRL) had its price target lowered by analysts at UBS Group AG from $250.00 to $215.00. They now have a "buy" rating on the stock.
Ratings data for CRL provided by MarketBeat
Stopped prediction by UBS_Group_AG for Charles River Labs Intl
Charles River Labs Intl
Start price
Target price
Perf. (%)
€184.90
08.08.24
08.08.24
€220.15
08.08.25
08.08.25
-3.81%
09:30
09:30
Charles River Labs Intl
Start price
Target price
Perf. (%)
€227.80
15.02.24
15.02.24
€269.47
15.02.25
15.02.25
-21.93%
09:30
09:30